Skip to content
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
Quest Diabetes
  • Diet & Nutrition
  • Lifestyle & Wellbeing
  • News & Research
  • Treatment & Management
  • Patient Narratives
  • Glycaemic Index
  • Carbohydrate Counting
Quest Diabetes
  • Treatment & Management

AI diabetes tools face accuracy and access challenges amid data rights push

As diabetes apps attempt to automate carbohydrate counting through photos, experts warn that accuracy remains inconsistent. Meanwhile, the future lies in harnessing personal glucose data, raising urgent questions about data access and patient empowerment. A growing cluster of diabetes apps…

  • apxadmin
  • August 6, 2026
  • Glycaemic Index

New guidelines help people with diabetes enjoy summer cookouts without guilt

Guidance from health agencies emphasises balance, portion control, and smart food choices to enable people living with diabetes to enjoy seasonal gatherings safely and deliciously. Summer cookouts can be a source of pleasure and pressure in equal measure for people…

  • apxadmin
  • August 6, 2026
  • News & Research

SAB Biotherapeutics advances type 1 diabetes programme with expanded clinical and manufacturing efforts

SAB Biotherapeutics progresses its lead type 1 diabetes treatment into further testing phases, expands manufacturing capacity, and receives strategic grants amid rising R&D investment and a significant stock index inclusion. SAB Biotherapeutics said its lead type 1 diabetes programme moved…

  • apxadmin
  • August 6, 2026
  • Glycaemic Index

Rice researchers develop immune shield for pancreatic cell transplants in diabetes

Scientists at Rice University have created a local immune buffer using IL-10 to protect transplanted pancreatic beta cells, extending their survival in diabetic mice and potentially revolutionising cell therapies for type 1 diabetes. Rice University researchers say they have found…

  • apxadmin
  • August 6, 2026
  • News & Research

Mounjaro may offer cardiovascular protection in people with type 2 diabetes, new study suggests

Research indicates that tirzepatide, the active ingredient in Mounjaro, not only helps control blood sugar and weight but also significantly reduces the risk of heart attacks and serious cardiovascular events in patients with type 2 diabetes and heart disease, signalling…

  • apxadmin
  • August 6, 2026
  • News & Research

Using GLP-1 drugs for PCOS fertility prep sparks cautious debate over safety and long-term effects

Women with polycystic ovary syndrome are increasingly using GLP-1 receptor agonists like Ozempic and Mounjaro to manage weight and insulin resistance as part of fertility preparation, raising questions about safety, timing, and long-term outcomes. GLP-1 drugs such as Ozempic, Wegovy…

  • apxadmin
  • August 6, 2026
  • Treatment & Management

Innovations and rising demand drive rapid growth in short-acting insulin market

The short-acting insulin market is forecast to expand significantly by 2030 and 2034, propelled by increasing diabetes prevalence, advances in delivery technology, and strategic industry moves towards biosimilars and product interchangeability. The short-acting insulin market is heading for steady expansion…

  • apxadmin
  • August 6, 2026
  • Patient Narratives

Gestational diabetes alters early brain response to food cues during pregnancy

A Lausanne study reveals that metabolic health during pregnancy influences how the brain processes food images, with pregnant women with gestational diabetes showing distinct electrical activity patterns within milliseconds of viewing food cues, impacting appetite and eating behaviour. Researchers in…

  • apxadmin
  • August 6, 2026
  • Glycaemic Index

New research suggests GLP-1 medications may reduce fracture risk in older adults with type 2 diabetes

A large-scale study indicates that GLP-1 receptor agonists could offer protective benefits against fractures in older type 2 diabetes patients, though further trials are needed to confirm the findings. Medications in the GLP-1 class, best known for treating diabetes and…

  • apxadmin
  • August 6, 2026
  • Diet & Nutrition

New standards emphasise ongoing, personalised support for effective diabetes management

Updated guidelines from the American Diabetes Association highlight the importance of continuous, personalised support involving healthcare professionals, family and peer networks to improve long-term diabetes outcomes. Diabetes is not a condition that can be kept in check simply by taking…

  • apxadmin
  • August 6, 2026
Prev
1 … 181 182 183 184 185 186 187 … 199
Next

Search

No results

Posts

Mainstream guidance shifts towards sustainable lifestyle changes for HbA1c management

September 7, 2026

Orange juice has a slight edge over apple juice for blood sugar

October 23, 2026

Canadian study suggests NHS England-style diabetes prevention programme offers cost-effective health benefits

October 6, 2026

Distinct early microbiome trajectories linked to type 1 diabetes risk in children

September 21, 2026

Green or ripe? How a banana’s ripeness changes its health benefits

October 20, 2026

Trending now

Why green and ripe plantains can affect blood sugar differently
New guidelines help people with diabetes enjoy summer cookouts without guilt
Gestational diabetes alters early brain response to food cues during pregnancy
Personal glucose pattern analyser offers targeted insights for diabetes management

Copyright © 2026 - QuestDiabetes.com

Disclaimer | Terms & Conditions | Privacy Policy